The process of innovative drug medical insurance admission in China is gradually accelerating,but the risk of admission decision-making is also increasing.Standardizing the application of real-world data can provide important evidence for medical insurance admission assessment,thereby reducing decision-making risks.This article analyzes the advantages and disadvantages of real-world data and application scenarios in medical insurance access,summarizes current policy frameworks and guidelines at home and abroad,and proposes research standards and application paths for real-world data in China's innovative drug medical insurance access,providing references for the application of real-world data research in medical insurance access.
维普
万方数据